Cancer Epidemiology Biomarkers & Prevention, Vol 5, Issue 10 835-844, Copyright © 1996 by American Association for Cancer Research

ARTICLES

Reproducibility studies and interlaboratory concordance for assays of serum hormone levels: estrone, estradiol, estrone sulfate, and progesterone

MH Gail, TR Fears, RN Hoover, DW Chandler, JL Donaldson, MB Hyer, D Pee, WV Ricker, PK Siiteri, FZ Stanczyk, JB Vaught and RG Ziegler
Biostatistics Branch, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA.

We conducted studies to measure sources of assay variability for estrone, estradiol, estrone sulfate, and progesterone for postmenopausal women (n = 5) and for women in the mid-follicular (n = 5) and mid-luteal (n = 5) phases of the menstrual cycle. A single blood sample from each woman was divided into 2.5-ml aliquots and stored at -70 degrees C, and sets of two aliquots were sent at monthly intervals to each of three laboratories (four for progesterone). Each aliquot was analyzed in duplicate. Thus, within each menstrual category, we were able to estimate the components of variance due to variation among women, variation among aliquots, variation among duplicate measurements, and variation among the 4 analysis days. Using the logarithm of assay measurements, we estimated the percentage of variance attributable to variation among women in each menstrual category, 100 rho, is the estimated intraclass correlation. For each assay, 100 rho exceeded 90% for mid-follicular and mid-luteal women. For postmenopausal women, values of 100 rho exceed 84% for estrone in two laboratories. Values of 100 rho were lower for progesterone in postmenopausal women, although a value of 84% was estimated from one laboratory. These studies indicate that estrogen assays over a period of 3 months permit reliable comparisons among women in a given menstrual category. Progesterone measurements are likewise reliable for women in the mid-follicular and mid-luteal phases but somewhat less satisfactory for postmenopausal women. These assessments of variability pertain only to laboratory techniques and do not allow for secular variation in intra-woman hormone levels. Moreover, although these measurements tend to be reliable enough for making comparisons among women, estimates of coefficients of variation for estrogens are about 10% for mid-follicular and mid-luteal phase women and about 11-20% for postmenopausal women. Coefficients of variation for progesterone are about 10% for mid-luteal, 20% for mid-follicular, and 30% for postmenopausal women.

This article has been cited by other articles:

				S. S. Tworoger, Y. Yasui, L. Chang, F. Z. Stanczyk, and A. McTiernan Specimen Allocation in Longitudinal Biomarker Studies: Controlling Subject-Specific Effects by Design Cancer Epidemiol. Biomarkers Prev., July 1, 2004; 13(7): 1257 - 1260. [Abstract] [Full Text] [PDF]

				T. R. Fears, R. G. Ziegler, J. L. Donaldson, R. T. Falk, R. N. Hoover, F. Z. Stanczyk, J. B. Vaught, and M. H. Gail Reproducibility Studies and Interlaboratory Concordance for Androgen Assays of Male Plasma Hormone Levels Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 785 - 789. [Abstract] [Full Text] [PDF]

				S. Rinaldi, H. Dechaud, C. Biessy, V. Morin-Raverot, P. Toniolo, A. Zeleniuch-Jacquotte, A. Akhmedkhanov, R. E. Shore, G. Secreto, A. Ciampi, E. Riboli, and R. Kaaks Reliability and Validity of Commercially Available, Direct Radioimmunoassays for Measurement of Blood Androgens and Estrogens in Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., July 1, 2001; 10(7): 757 - 765. [Abstract] [Full Text] [PDF]

				M. Kabuto, S. Akiba, R. G. Stevens, K. Neriishi, and C. E. Land A Prospective Study of Estradiol and Breast Cancer in Japanese Women Cancer Epidemiol. Biomarkers Prev., June 1, 2000; 9(6): 575 - 579. [Abstract] [Full Text]

				T. R. Fears, R. G. Ziegler, J. L. Donaldson, R. T. Falk, R. N. Hoover, F. Z. Stanczyk, J. B. Vaught, and M. H. Gail Reproducibility Studies and Interlaboratory Concordance for Androgen Assays in Female Plasma Cancer Epidemiol. Biomarkers Prev., April 1, 2000; 9(4): 403 - 412. [Abstract] [Full Text]

				R. T. Falk, M. H. Gail, T. R. Fears, S. C. Rossi, F. Stanczyk, H. Adlercreutz, P. Kiura, K. Wahala, J. L. Donaldson, J. B. Vaught, C.-M. Fillmore, R. N. Hoover, and R. G. Ziegler Reproducibility and Validity of Radioimmunoassays for Urinary Hormones and Metabolites in Pre- and Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., June 1, 1999; 8(6): 567 - 577. [Abstract] [Full Text]

				A. Shibata, M. M. Lee, and P. B. Meyer Laboratory Assay Reproducibility of Serum Estrogens in Umbilical Cord Blood Samples Cancer Epidemiol. Biomarkers Prev., February 1, 1999; 8(2): 147 - 151. [Abstract] [Full Text]

				M. C. Bosland Chapter 2: The Role of Steroid Hormones in Prostate Carcinogenesis J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 39 - 66. [Abstract] [Full Text] [PDF]

				M. Garcia-Closas, S. E. Hankinson, S.-m. Ho, D. C. Malins, N. L. Polissar, S. N. Schaefer, Y. Su, and M. A. Vinson Chapter 9: Factors Critical to the Design and Execution of Epidemiologic Studies and Description of an Innovative Technology to Follow the Progression From Normal to Cancer Tissue J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 147 - 156. [Abstract] [Full Text] [PDF]

				R. Ballard-Barbash, M. R. Forman, and V. Kipnis Dietary Fat, Serum Estrogen Levels, and Breast Cancer Risk: a Multifaceted Story J Natl Cancer Inst, March 17, 1999; 91(6): 492 - 494. [Full Text]